Improvement Seen in Reproductive Hormone Levels With Keto Diet in PCOS
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Sept. 14, 2023 -- For women with polycystic ovary syndrome (PCOS), following a ketogenic diet is associated with significant improvement in reproductive hormone levels, according to research published online Sept. 7 in the Journal of the Endocrine Society.
Karniza Khalid, M.B.B.S., from the National Institutes of Health in Kuala Lumpur, Malaysia, and colleagues pooled evidence from clinical trials to examine the effects of a ketogenic diet on reproductive hormones (luteinizing hormone/follicle-stimulating hormone ratio, free testosterone, serum progesterone) as well as evidence of change in weight.
The researchers found that among women with PCOS, there was significant improvement in reproductive hormone levels following 45 days or more of a ketogenic diet intervention, with a reduced luteinizing hormone/follicle-stimulating hormone ratio, reduced serum free testosterone, and an increase in serum sex hormone-binding globulin. In all included studies, significant weight loss was observed.
"We found an association between the ketogenic diet and an improvement in reproductive hormone levels, which influence fertility, in women with PCOS," Khalid said in a statement. "These findings have important clinical implications, especially for endocrinologists, gynecologists, and dieticians who, in addition to medical treatment, should carefully plan and customize individual diet recommendations for women with PCOS."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.